Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Worldwide Biosimilar Market Research Report 2021 by Type, Application, Participants and Countries, COVID-19 Impact, Forecast Year to 2026

  • PRO4445685
  • 115 Pages
  • May 2021
  • Pharmaceuticals
Download Sample    Get Discount   
 
Due to the high popularity of this product/service in North America and Asia, the growth trend of Biosimilar in recent years and the growth of consumers' demand is expected to drive the global Biosimilar market.

Geographically, the global Biosimilar market is divided into North America, Europe, Latin America, Asia Pacific, Middle East & Africa.

North America, Asia and Europe have significant position in the this market, big players operating in there. The U.S. is accounting for a major share of the total Biosimilar market in North America.

Significant participants active in the global Biosimilar market include: Hospira (Pfizer), Gelgen Biopharma, CP Guojian Pharmacy, 3sbio, Teva Pharmaceutical, Sun pharma, MYLAN, Changchun High Tech, SANDOZ (NOVARTIS), Biotech Pharma...

Global Biosimilar Market Segmentation:

Biosimilar market, by Biosimilar type:

Predictive Testing

Carrier Testing

Prenatal And Newborn Testing

Diagnostic Testing

Pharmacogenomic Testing

…

Biosimilar market, by Application:

Infectious Disease

Blood Screening

Genetic Testing

Oncology Testing

…

Biosimilar Market Research Report 2014-2026, by region:

North America

The U.S.

Canada

Europe

Germany

UK

France

Italy

Spain

Rest of Europe

Latin America

Mexico

Brazil

Argentina

Pan Asia Pacific

China

Japan

South Korea

South East Asia Region

India

Australia

Middle East and Africa

Saudi Arabia

UAE

Qatar

Egypt

Nigeria

South Africa

Rest of MEA

The database is running updated by a group of research experts to always reflect the latest trends and information.

Table of Content

1. Introduction

1.1 Definition of the Market

1.2 Research Purpose

1.3 Scope of the Study

1.4 Stakeholders

1.5 Geography Coverage

1.6 Currency Under Consideration

1.7 Volume Units

1.8 Review Cycle

1.9 Summary and Key Findings of the Research

2 Research Methodology

2.1 Research Data

2.1.1 Secondary Data

2.1.2 Primary Data

2.2 Market Size Estimation

2.2.1 Bottom-Up Approach

2.2.2 Top-Down Approach (Involves time, Space, and Persons)

2.3 Data Triangulation

2.4 Assumptions

2.5 Hypothesis of this Research, Clear, Specific, and Testable Statement of This Research

2.6 Limitations of Our Study

2.7 Scene Based Modeling

2.8 Covid-19 Impact/Evaluation

3. Market Dynamics

3.1 Driving Factors

3.1.1 Rising Demand in one or More of the Following Regions: North America, Europe, Asia-Pacific, Latin America, Middle East & Africa

3.1.2 Increasing Use of Biosimilar by Different End-User/Applications

3.2 Restraints and Challenges in the Market

3.3 Opportunities

4. Global Biosimilar Market-Segmentation

4.1 By Type

4.1.1 Predictive Testing

4.1.2 Carrier Testing

4.1.3 Prenatal And Newborn Testing

4.1.4 Diagnostic Testing

4.1.5 Pharmacogenomic Testing

4.2 By End-User/Application Industry

4.2.1 Infectious Disease

4.2.2 Blood Screening

4.2.3 Genetic Testing

4.2.4 Oncology Testing

4.3 By Geography

4.3.1 North America Biosimilar Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)

4.3.1.1 North America Biosimilar Production from 2014-2020

4.3.1.2 North America Biosimilar Consumption from 2014-2020

4.3.1.3 North America Biosimilar Import and Export from 2014-2020

4.3.1.4 North America Biosimilar Market Value ($) and Growth (%) by Type from 2019-2020

4.3.1.5 North America Biosimilar Market Value ($) and Growth (%) by Application from 2019-2020

4.3.1.6 North America Biosimilar Market Value ($) and Growth (%) by Countries from 2019-2020

4.3.1.7 Top North America Biosimilar Participants Value ($) and Market Share (%) in 2019

4.3.2 Europe Biosimilar Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)

4.3.2.1 Europe Biosimilar Production from 2014-2020

4.3.2.2 Europe Biosimilar Consumption from 2014-2020

4.3.2.3 Europe Biosimilar Import and Export from 2014-2020

4.3.2.4 Europe Biosimilar Market Value ($) and Growth (%) by Type from 2019-2020

4.3.2.5 Europe Biosimilar Value ($) and Growth (%) by Application from 2019-2020

4.3.2.6 Europe Biosimilar Market Value ($) and Growth (%) by Countries from 2019-2020

4.3.2.7 Top Europe Biosimilar Participants Value ($) and Market Share (%) in 2019

4.3.3 Asia-Pacific Biosimilar Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)

4.3.3.1 Asia-Pacific Biosimilar Production from 2014-2020

4.3.3.2 Asia-Pacific Biosimilar Consumption from 2014-2020

4.3.3.3 Asia-Pacific Biosimilar Import and Export from 2014-2020

4.3.3.4 Asia-Pacific Biosimilar Value ($) and Growth (%) by Type from 2019-2020

4.3.3.5 Asia-Pacific Biosimilar Value ($) and Growth (%) by Application from 2019-2020

4.3.3.6 Asia-Pacific Biosimilar Value ($) and Growth (%) by Countries from 2019-2020

4.3.3.7 Top Asia-Pacific Biosimilar Participants Value ($) and Market Share (%) in 2019

4.3.4 Latin America Biosimilar Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)

4.3.4.1 Latin America Biosimilar Production from 2014-2020

4.3.4.2 Latin America Biosimilar Consumption from 2014-2020

4.3.4.3 Latin America Biosimilar Import and Export from 2014-2020

4.3.4.4 Latin America Biosimilar Value ($) and Growth (%) by Type from 2019-2020

4.3.4.5 Latin America Biosimilar Value ($) and Growth (%) by Application from 2019-2020

4.3.4.6 Latin America Biosimilar Value ($) and Growth (%) by Countries from 2019-2020

4.3.4.7 Top Latin America Biosimilar Participants Value ($) and Market Share (%) in 2019

4.3.5 Middle East & Africa Biosimilar Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)

4.3.5.1 Middle East & Africa Biosimilar Production from 2014-2020

4.3.5.2 Middle East & Africa Biosimilar Consumption from 2014-2020

4.3.5.3 Middle East & Africa Biosimilar Import and Export from 2014-2020

4.3.5.4 Middle East & Africa Biosimilar Value ($) and Growth (%) by Type from 2019-2020

4.3.5.5 Middle East & Africa Biosimilar Value ($) and Growth (%) by Application from 2019-2020

4.3.5.6 Middle East & Africa Biosimilar Value ($) and Growth (%) by Countries from 2019-2020

4.3.5.7 Top Middle East & Africa Biosimilar Participants Value ($) and Market Share (%) in 2019

5. Competitive Intelligence – Company Profiles

5.1 Hospira (Pfizer)

5.1.1 Hospira (Pfizer) Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

5.1.2 Hospira (Pfizer) Sales, Growth Rate and Global Market Share from 2014-2020

5.2 Gelgen Biopharma

5.2.1 Gelgen Biopharma Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

5.2.2 Gelgen Biopharma Sales, Growth Rate and Global Market Share from 2014-2020

5.3 CP Guojian Pharmacy

5.3.1 CP Guojian Pharmacy Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

5.3.2 CP Guojian Pharmacy Sales, Growth Rate and Global Market Share from 2014-2020

5.4 3sbio

5.4.1 3sbio Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

5.4.2 3sbio Sales, Growth Rate and Global Market Share from 2014-2020

5.5 Teva Pharmaceutical

5.5.1 Teva Pharmaceutical Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

5.5.2 Teva Pharmaceutical Sales, Growth Rate and Global Market Share from 2014-2020

5.6 Sun pharma

5.6.1 Sun pharma Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

5.6.2 Sun pharma Sales, Growth Rate and Global Market Share from 2014-2020

5.7 MYLAN

5.7.1 MYLAN Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

5.7.2 MYLAN Sales, Growth Rate and Global Market Share from 2014-2020

5.8 Changchun High Tech

5.8.1 Changchun High Tech Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

5.8.2 Changchun High Tech Sales, Growth Rate and Global Market Share from 2014-2020

5.9 SANDOZ (NOVARTIS)

5.9.1 SANDOZ (NOVARTIS) Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

5.9.2 SANDOZ (NOVARTIS) Sales, Growth Rate and Global Market Share from 2014-2020

5.10 Biotech Pharma

5.10.1 Biotech Pharma Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

5.10.2 Biotech Pharma Sales, Growth Rate and Global Market Share from 2014-2020

6. Investment Analysis

6.1 Fundamental Analysis (Porter's Five Forces Analysis)

6.2 Technical Preparation Analysis

6.3 Risk Evaluating Analysis

6.4 Estimated Investment Pay-Back Period

7. Future Forecast of the Global Biosimilar Market from 2021-2026

7.1 Future Forecast of Global Biosimilar Market from 2021-2026 Segment by Region

7.2 Future Forecast of the Global Biosimilar Market from 2021-2026 Segment by Types

7.3 Future Forecast of the Global Biosimilar Market from 2021-2026 Segment by End-User/Applications

8 Appendix

8.1 Discussion Guide

8.2 Related Reports

8.3 Author List

9 Disclaimer

List of Tables and Figures

Global Biosimilar Market Value ($) and Growth Rate of Biosimilar from 2014-2026

Global Biosimilar Production and Growth Rate Segment by Product Types from 2014-2026F

Global Biosimilar Consumption and Growth Rate Segment by End-User/Application from 2014-2026E

Table Driving Factors for this Market (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa)

Table Global Biosimilar Production and Growth Rate Segment by Product Types from 2014-2020

Table Global Biosimilar Value ($) and Growth Rate Segment by Product Types from 2014-2020

Figure Predictive Testing of Biosimilar

Figure Carrier Testing of Biosimilar

Figure Prenatal And Newborn Testing of Biosimilar

Figure Diagnostic Testing of Biosimilar

Figure Pharmacogenomic Testing of Biosimilar

Table Global Biosimilar Consumption and Growth Rate Segment by End-User/Application from 2014-2020

Table Global Biosimilar Value ($) and Growth Rate Segment by End-User/Application from 2014-2020

Figure Infectious Disease of Biosimilar

Figure Blood Screening of Biosimilar

Figure Genetic Testing of Biosimilar

Figure Oncology Testing of Biosimilar

Table Global Biosimilar Production Value ($) by Regions

Table Global Biosimilar Production Value Share by Regions

Table Global Biosimilar Production by Regions

Table Global Biosimilar Production Share by Regions

Table Global Biosimilar Consumption by Regions

Table Global Biosimilar Consumption Share by Regions

Figure North America Biosimilar Production and Growth Rate from 2014-2020

Figure North America Biosimilar Consumption and Growth Rate from 2014-2020

Table North America Biosimilar Import and Export from 2014-2020

Table North America Biosimilar Value ($) and Growth (%) by Type from 2019-2020

Table North America Biosimilar Value ($) and Growth (%) by Application from 2019-2020

Table North America Biosimilar Value ($) and Growth (%) by Countries from 2019-2020

Table Top North America Biosimilar Participants Value ($) and Market Share (%) in 2019

Figure Europe Biosimilar Production and Growth Rate from 2014-2020

Figure Europe Biosimilar Consumption and Growth Rate from 2014-2020

Table Europe Biosimilar Import and Export from 2014-2020

Table Europe Biosimilar Value ($) and Growth (%) by Type from 2019-2020

Table Europe Biosimilar Value ($) and Growth (%) by Application from 2019-2020

Table Europe Biosimilar Market Value ($) and Growth (%) by Countries from 2019-2020

Table Top Europe Biosimilar Participants Value ($) and Market Share (%) in 2019

Figure Asia-Pacific Biosimilar Production and Growth Rate from 2014-2020

Figure Asia-Pacific Biosimilar Consumption and Growth Rate from 2014-2020

Table Asia-Pacific Biosimilar Import and Export from 2014-2020

Table Asia-Pacific Biosimilar Value ($) and Growth (%) by Type from 2019-2020

Table Asia-Pacific Biosimilar Value ($) and Growth (%) by Application from 2019-2020

Table Asia-Pacific Biosimilar Value ($) and Growth (%) by Countries from 2019-2020

Table Top Asia-Pacific Biosimilar Participants Value ($) and Market Share (%) in 2019

Figure Latin America Biosimilar Production and Growth Rate from 2014-2020

Figure Latin America Biosimilar Consumption and Growth Rate from 2014-2020

Table Latin America Biosimilar Import and Export from 2014-2020

Table Latin America Biosimilar Value ($) and Growth (%) by Type from 2019-2020

Table Latin America Biosimilar Value ($) and Growth (%) by Application from 2019-2020

Table Latin America Biosimilar Value ($) and Growth (%) by Countries from 2019-2020

Table Top Latin America Biosimilar Participants Value ($) and Market Share (%) in 2019

Figure Middle East & Africa Biosimilar Production and Growth Rate from 2014-2020

Figure Middle East & Africa Biosimilar Consumption and Growth Rate from 2014-2020

Table Middle East & Africa Biosimilar Import and Export from 2014-2020

Table Middle East & Africa Biosimilar Value ($) and Growth (%) by Type from 2019-2020

Table Middle East & Africa Biosimilar Value ($) and Growth (%) by Application from 2019-2020

Table Middle East & Africa Biosimilar Value ($) and Growth (%) by Countries from 2019-2020

Table Top Middle East & Africa Biosimilar Participants Value ($) and Market Share (%) in 2019

Table Hospira (Pfizer) Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

Figure Hospira (Pfizer) Sales and Growth Rate from 2014-2020

Figure Hospira (Pfizer) Revenue ($), Gross Margin and Global Market Share from 2014-2020

Table Gelgen Biopharma Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

Figure Gelgen Biopharma Sales and Growth Rate from 2014-2020

Figure Gelgen Biopharma Revenue ($), Gross Margin and Global Market Share from 2014-2020

Table CP Guojian Pharmacy Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

Figure CP Guojian Pharmacy Sales and Growth Rate from 2014-2020

Figure CP Guojian Pharmacy Revenue ($), Gross Margin and Global Market Share from 2014-2020

Table 3sbio Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

Figure 3sbio Sales and Growth Rate from 2014-2020

Figure 3sbio Revenue ($), Gross Margin and Global Market Share from 2014-2020

Table Teva Pharmaceutical Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

Figure Teva Pharmaceutical Sales and Growth Rate from 2014-2020

Figure Teva Pharmaceutical Revenue ($), Gross Margin and Global Market Share from 2014-2020

Table Sun pharma Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

Figure Sun pharma Sales and Growth Rate from 2014-2020

Figure Sun pharma Revenue ($), Gross Margin and Global Market Share from 2014-2020

Table MYLAN Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

Figure MYLAN Sales and Growth Rate from 2014-2020

Figure MYLAN Revenue ($), Gross Margin and Global Market Share from 2014-2020

Table Changchun High Tech Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

Figure Changchun High Tech Sales and Growth Rate from 2014-2020

Figure Changchun High Tech Revenue ($), Gross Margin and Global Market Share from 2014-2020

Table SANDOZ (NOVARTIS) Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

Figure SANDOZ (NOVARTIS) Sales and Growth Rate from 2014-2020

Figure SANDOZ (NOVARTIS) Revenue ($), Gross Margin and Global Market Share from 2014-2020

Table Biotech Pharma Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

Figure Biotech Pharma Sales and Growth Rate from 2014-2020

Figure Biotech Pharma Revenue ($), Gross Margin and Global Market Share from 2014-2020

Table Global Biosimilar Value ($) and Growth Rate Forecast by Regions (2021-2026)

Table Global Biosimilar Production and Growth Rate Forecast by Regions (2021-2026)

Table Global Biosimilar Consumption and Growth Rate Forecast by Regions (2021-2026)

Table Global Biosimilar Production and Growth Rate Forecast by Types (2021-2026)

Table Global Biosimilar Consumption and Growth Rate Forecast by End-User/Applications (2021-2026)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390